Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20.8M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
61.3M
-
Shares change
-
+5.43M
-
Total reported value, excl. options
-
$44M
-
Value change
-
+$4.08M
-
Put/Call ratio
-
0
-
Number of buys
-
18
-
Number of sells
-
-24
-
Price
-
$0.72
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q1 2023
67 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.3M shares
.
Largest 10 shareholders include FMR LLC (7.77M shares), BML Capital Management, LLC (7.07M shares), MORGAN STANLEY (6.96M shares), BANK OF AMERICA CORP /DE/ (5.59M shares), Versant Venture Management, LLC (5.07M shares), COMMODORE CAPITAL LP (5M shares), GOLDMAN SACHS GROUP INC (4.56M shares), VANGUARD GROUP INC (4.14M shares), BlackRock Inc. (2.04M shares), and Sonic GP LLC (2M shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.